Profil
Mr. Adam Townsend is a President, Chief Executive Officer & Director at Merida Biosciences, Inc. He is on the Board of Directors at Merida Biosciences, Inc. Mr. Townsend was previously employed as a Chief Operating Officer by Apellis Pharmaceuticals, Inc., a Senior Vice President-Corporate Development by Biogen, Inc., and a General Manager-UK, Ireland & Nordic Region by EUSA Pharma, Inc. He received his undergraduate degree from Royal Holloway University of London.
Postes actifs de Adam Townsend
| Sociétés | Poste | Début |
|---|
Anciens postes connus de Adam Townsend
| Sociétés | Poste | Fin |
|---|---|---|
| APELLIS PHARMACEUTICALS, INC. | Directeur des opérations | 21/02/2025 |
| BIOGEN INC. | Corporate Officer/Principal | 01/10/2018 |
EUSA Pharma, Inc.
EUSA Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and researches pharmaceutical products | Corporate Officer/Principal | 01/03/2010 |
Formation de Adam Townsend
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Biogen, Inc.
Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
EUSA Pharma, Inc.
EUSA Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and researches pharmaceutical products | Health Technology |
Apellis Pharmaceuticals, Inc.
Apellis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics and drug delivery technologies to address chronic inflammatory diseases | Health Technology |
Royal Holloway University of London
Royal Holloway University of London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
















